Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Sage Therapeutics, Inc. - Common Stock (NQ:SAGE)

8.680 UNCHANGED
Last Price Updated: 4:00 PM EDT, Jul 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Sage Therapeutics, Inc. - Common Stock

< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
News headline image
What 8 Analyst Ratings Have To Say About Sage Therapeutics ↗
Sage Therapeutics (NASDAQ:SAGE) has observed the following analyst ratings ... 
Via Benzinga
News headline image
10 Biggest Price Target Changes For Wednesday ↗
Needham boosted Paycom Software, Inc. (NYSE:PAYC) ... 
Via Benzinga
News headline image
Sage Therapeutics Inc (SAGE) Q3 2021 Earnings Call Transcript ↗
SAGE earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
How Bad Are Sage Therapeutics's Earnings? | Return On Capital Employed ↗
Sage Therapeutics (NASDAQ:SAGE) brought in sales totaling $1.44 million during Q3 according to data provided by Benzinga Pro. However, earnings decreased 21.17%, resulting in a... 
Via Benzinga
Artificial Intelligence Could Be About To Replace Your Doctor
FN Media Group Presents GlobalInvestmentDaily.com Market Commentary London – November 2, 2021 – The US health and medical insurance industry is a $1.1-trillion maze that is impossible to navigate. And... 
Via FinancialNewsMedia
Topics Artificial Intelligence
News headline image
Earnings Scheduled For November 2, 2021 ↗
Companies Reporting Before The Bell • Thomson Reuters (NYSE:TRI) is expected to report quarterly earnings at $0.48 per share on revenue of $1.86 billion. •... 
Via Benzinga
News headline image
Analyst Ratings For Sage Therapeutics ↗
Sage Therapeutics (NASDAQ:SAGE) has observed the following analyst ratings... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus SAB Spikes On Analyst Action SAB Biotherapeutics, Inc. (NASDAQ: SABS) shares... 
Via Benzinga
News headline image
Sage Therapeutics Announces Third Quarter 2021 Financial Results and Highlights Pipeline and Business Progress
From Sage Therapeutics, Inc.
Via Business Wire
News headline image
Preview: Sage Therapeutics's Earnings ↗
Sage Therapeutics (NASDAQ:SAGE) is set to give its latest quarterly earnings report on Tuesday, 2021-11-02. Here's what investors need to know before the announcement. Analysts... 
Via Benzinga
News headline image
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline ↗
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc... 
Via Benzinga
Ketamine’s Potential As A Treatment For Depression Has Drawn Major Industry Attention
Palm Beach, FL –October 27, 2021 – FinancialNewsMedia.com News Commentary – Among the race to see what psychedelic drugs can do, ketamine is a step ahead of all other drugs, because it has already been... 
Via FinancialNewsMedia
News headline image
B. Riley Sees 'Significant Potential' In This Beaten-Up Biotech Stock ↗
B. Riley analyst calls Seelos Therapeutics Inc (NASDAQ: 
Via Benzinga
News headline image
Sage Therapeutics to Report Third Quarter 2021 Financial Results on Tuesday, November 2, 2021
From Sage Therapeutics, Inc.
Via Business Wire
News headline image
What 7 Analyst Ratings Have To Say About Sage Therapeutics ↗
Sage Therapeutics (NASDAQ:SAGE) has observed the following analyst ratings... 
Via Benzinga
News headline image
Abbot Labs and Biogen Outshine Novavax in the Health Care Sector ↗
Just before Tuesday’s close, Netflix (NASDAQ: NFLX) reported better-than-expected earnings by adding 4.4 million subscribers in the third quarter. The company... 
Via Benzinga
News headline image
10 Biggest Price Target Changes For Wednesday ↗
Mizuho cut QUALCOMM Incorporated (NASDAQ: QCOM) price target from $180 to $165. QUALCOMM shares fell 0.3% to $132.13 in pre-market trading. Deutsche Bank raised the price... 
Via Benzinga
News headline image
Sage Therapeutics and Biogen Announce Plans to Submit a New Drug Application (NDA) for Zuranolone to the U.S. Food & Drug Administration in the Second Half of 2022 with Rolling Submission Expected to Start in Early 2022
From Sage Therapeutics, Inc.
Via Business Wire
A.I. Breakthrough Could Disrupt the $11 Trillion Medical Sector
FN Media Group Presents Oilprice.com Market Commentary London – October 18, 2021 – A massive disruption now appears imminent in one of the world’s largest – and most important – industries. In much the... 
Via FinancialNewsMedia
Topics Artificial Intelligence
News headline image
Rising Oil Prices and Yields Makes Market Navigation More Complex ↗
Bitcoin (/BTC) topped $50,000 this morning for the first since May, but traders may be more focused on oil prices and yields. Crude oil (/CL) is continuing its rise... 
Via Benzinga
News headline image
Sage Therapeutics and Biogen Announce Consistent Clinically Meaningful Data for Zuranolone Across the LANDSCAPE and NEST Clinical Development Programs Presented at the European College of Neuropsychopharmacology (ECNP) Congress
From Sage Therapeutics, Inc.
Via Business Wire
News headline image
Sage Therapeutics Launches SageCitizen Social Impact Initiative
From Sage Therapeutics
Via Business Wire
News headline image
Sage Therapeutics Appoints Chris Benecchi as Chief Commercial Officer
From Sage Therapeutics
Via Business Wire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For September 23, 2021 ↗
Upgrades Barclays upgraded the previous rating for Warner Music Group Corp (NASDAQ: 
Via Benzinga
News headline image
Why Sage Therapeutics Shares Are Trading Higher Today ↗
Sage Therapeutics (NASDAQ:SAGE) shares are trading higher after the company announced it received Fast Track Designation for SAGE-718 or the treatment of Huntington's... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 14) Alcon Inc. (NYSE: ALC)... 
Via Benzinga
News headline image
Sage Therapeutics Receives Fast Track Designation for SAGE-718 for the Treatment of Huntington’s Disease
From Sage Therapeutics, Inc.
Via Business Wire
News headline image
Sage Therapeutics to Present at the Morgan Stanley Global Healthcare Conference
From Sage Therapeutics, Inc.
Via Business Wire
News headline image
5 Value Stocks In The Healthcare Sector ↗
The Meaning Behind Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
On Friday morning, 155 companies achieved new lows for the year. Interesting Points: Marqeta (NASDAQ:MQ) was the largest firm on a market cap basis to set a new 52-... 
Via Benzinga
< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.